| Drug Class: |
Combination of growth hormone secretagogue peptide (Ipamorelin) and growth hormone-releasing hormone (GHRH) analogue (Tesamorelin) |
| Molecular Formula: |
Ipamorelin: C38H49N9O5 Tesamorelin: C221H366N72O67S |
| Molecular Weight: |
Ipamorelin: ~711.9 g/mol Tesamorelin: ~5135 g/mol |
| Form: |
Lyophilized peptide blend (vial) |
| Purity: |
Not specified (typically ≥98% peptide purity for research-grade peptides) |
| Sequence: |
Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ Tesamorelin: 44-amino-acid GHRH analogue with trans-3-hexenoic acid modification |
| Brand: |
Dragon Pharma |
| Substances: |
Ipamorelin + Tesamorelin |
| Concentration: |
10 mg (combined peptide blend) |
Product Disclaimer: Research Purposes Only
This product is intended strictly for laboratory research and in vitro analysis. It is not approved for human or animal use. Any form of internal administration is prohibited by law. Handling should be limited to qualified and licensed professionals. This item is not classified as a pharmaceutical, dietary supplement, or cosmetic product. For educational and scientific research use only.
What is Dragon Pharma Ipamorelin/Tesamorelin Blend?
Ipamorelin/Tesamorelin Blend is a synergistic peptide combination designed to enhance endogenous growth hormone (GH) release through complementary mechanisms. Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates GH release via ghrelin receptor activation with minimal impact on cortisol or prolactin. Tesamorelin, on the other hand, is a stabilized analog of growth hormone–releasing hormone (GHRH) that promotes pituitary stimulation through a separate receptor pathway. When combined in a single vial, this blend supports amplified pulsatile GH secretion, potentially enhancing IGF-1 production, body composition optimization, and recovery research outcomes. The dual-pathway approach makes it particularly relevant in structured endocrine and metabolic studies.
Mechanism of Action:
The Ipamorelin/Tesamorelin Blend works by targeting two distinct but complementary receptors within the hypothalamic–pituitary axis. Tesamorelin activates GHRH receptors on the anterior pituitary, increasing the amplitude of natural GH pulses. Simultaneously, Ipamorelin binds to the GHS-R1a (ghrelin receptor), further stimulating GH release through a separate signaling cascade. This dual activation enhances overall growth hormone output while maintaining a physiologic pulsatile pattern. The increase in circulating GH promotes hepatic secretion of IGF-1 (Insulin-like Growth Factor-1), which drives anabolic signaling, tissue repair, lipolysis, and metabolic adaptation. Because Ipamorelin is highly selective, it minimizes unwanted elevations in cortisol and prolactin compared to earlier secretagogues, making the blend attractive for balanced GH pathway research.
Benefits:
- Amplifies natural growth hormone secretion through dual pathways
- Supports increased IGF-1 production and anabolic signaling
- Promotes lean mass development and fat metabolism research
- Enhances recovery and tissue-regeneration investigations
Research Applications:
- Studying synergistic GHRH and GHS receptor activation
- Investigating body composition and visceral fat modulation
- Exploring muscle repair and connective tissue regeneration
- Evaluating endocrine axis responsiveness and GH pulsatility
Dosing Instructions:
- Dosing: Reconstitute lyophilized blend with bacteriostatic water before use
- Daily Dose: Common research range 100–300 mcg of each peptide per administration
- Route: Subcutaneous injection
- Duration: 8–16 weeks depending on protocol objectives
- Frequency: 1–2 times daily, often timed around fasting periods
- Recommended Cycles: Structured cycles followed by evaluation of hormonal markers
- PCT: Not typically required; monitor GH and IGF-1 levels post-cycle
Stacking With Other Products:
- CJC-1295 (no DAC) for additional GHRH pathway support
- Hexarelin in advanced GH-amplification studies
- IGF-1 LR3 for downstream anabolic pathway research
- GHK-CU for regenerative and connective tissue protocols
Side Effects:
- Mild water retention
- Temporary injection-site irritation
- Possible headache during adaptation
- Rare transient fatigue
Contraindications:
- Active malignancy due to GH stimulation concerns
- Uncontrolled diabetes or severe insulin resistance
- Pregnancy or breastfeeding
- Individuals with untreated pituitary disorders
Conclusion
The Ipamorelin/Tesamorelin Blend represents a strategic dual-peptide approach to stimulating endogenous growth hormone release. By combining selective ghrelin receptor activation with GHRH receptor stimulation, this blend enhances pulsatile GH output while supporting physiologic balance. The resulting increase in IGF-1 and anabolic signaling pathways makes it highly relevant in research focusing on body composition, recovery biology, and endocrine optimization. With careful monitoring and structured protocols, this combination provides valuable insight into the synergistic dynamics of the growth hormone axis and continues to be a prominent tool in advanced peptide research.
References:
- Ghigo E, et al. "Growth Hormone-Releasing Peptides and GHRH Analogs." Endocrine Reviews.
- Falutz J, et al. "Tesamorelin Effects on Body Composition." Journal of Clinical Endocrinology & Metabolism.
- Smith RG, et al. "Ghrelin Receptor Agonists and GH Secretion." Trends in Endocrinology & Metabolism.
- Bowers CY. "Mechanisms of Growth Hormone Secretagogues." Frontiers in Neuroendocrinology.

Ipamorelin/Tesamorelin Blend FAQ
✔️ What is the Ipamorelin/Tesamorelin Blend?
The Ipamorelin/Tesamorelin Blend is a synthetic peptide combination designed to stimulate natural growth hormone (GH) release, enhancing muscle growth, fat metabolism, and recovery.
✔️ How does this peptide blend work?
Ipamorelin mimics ghrelin, triggering pulsatile GH secretion, while Tesamorelin acts as a GHRH analogue, increasing the pituitary gland's GH output. Together, they optimize growth hormone levels safely and effectively.
✔️ What are the primary benefits of using this blend?
Key benefits include lean muscle gain, accelerated fat loss, improved recovery, enhanced joint health, better sleep, and anti-aging support due to elevated GH and IGF-1 levels.
✔️ How should the Ipamorelin/Tesamorelin Blend be administered?
It is typically administered via subcutaneous injection. Proper dosage and timing depend on individual goals and should follow medical guidance for maximum efficacy and safety.
✔️ Is this peptide blend safe?
When used responsibly, the Ipamorelin/Tesamorelin Blend is considered safe and well-tolerated. Possible mild side effects include temporary water retention, tingling, or increased hunger.
✔️ Can this blend aid in fat loss?
Yes, the combination boosts GH secretion, which promotes lipolysis (fat breakdown) while helping preserve lean muscle mass, making it highly effective for body recomposition.
✔️ How long before I see results?
Muscle definition and recovery improvements may be noticeable in 4–6 weeks, while fat loss results can take 6–12 weeks depending on diet, training, and consistency.
✔️ Can the blend improve sleep and recovery?
Yes, the Ipamorelin/Tesamorelin Blend enhances deep sleep quality, which allows the body to maximize cellular repair, recovery, and growth hormone pulses.
✔️ Can this peptide be stacked with other compounds?
Yes, it can be combined with other peptides like CJC-1295 or BPC-157 to enhance recovery, joint repair, and overall anabolic effects. Stacking should always follow professional guidance.
✔️ How should I store this peptide blend?
Store lyophilized Ipamorelin/Tesamorelin in the refrigerator at 2–8°C (36–46°F), away from light and moisture. Once reconstituted, use it within the recommended timeframe to maintain potency and safety.
Ipamorelin/Tesamorelin Blend – Storage & Safety Essentials
Protect Potency with Proper Storage
Maintaining the effectiveness of your Ipamorelin/Tesamorelin Blend requires precise storage conditions:
- Keep the vial refrigerated at 2–8°C.
- Shield from direct sunlight, heat, and humidity to preserve peptide stability.
- Avoid freezing unless specified, as it can compromise integrity and potency.
Safe Handling Practices
Handling this peptide safely ensures both personal safety and product quality:
- Always use sterile needles and syringes for reconstitution and administration.
- Limit freeze-thaw cycles to avoid degradation.
- Keep the vial tightly sealed to prevent contamination.
Reconstitution & Usage Instructions
Correct preparation maintains stability and efficacy:
- Reconstitute with bacteriostatic water immediately before use.
- Mix gently—avoid shaking vigorously to protect the peptide structure.
- Any leftover solution should be stored refrigerated and used within the recommended timeframe.
Safety & Disposal Recommendations
Ensure safe handling for both user and environment:
- Handle in a clean, controlled setting.
- Dispose of used syringes, needles, and empty vials following biohazard guidelines.
- Do not use if the solution appears cloudy, discolored, or contains particles.
Summary
Following proper storage, handling, and reconstitution procedures guarantees that your Ipamorelin/Tesamorelin Blend remains potent, safe, and effective. These steps maximize results while minimizing the risk of contamination or peptide degradation.